Clorox Co (NYSE:CLX) currently has a daily average trading volume of 1.63M but it saw 1155293 shares traded in last market. With a market cap of 15.98B USD, the company’s current market price of $129.65 came falling about -0.34 while comparing to the previous closing price of $130.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $171.37 and as low as $129.03.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which upgraded the stock as “Equal Weight” in its note to investors issued on January 07, 2025, recommending a price target of $157 for it. TD Cowen upgraded its recommendation for the stock as a “Hold” from “Sell” on November 06, 2024 while assigning a price target range of $155-$170. Jefferies also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $174 and $187.
Over the week, CLX’s stock price is moving -0.39% down while it is -6.32% when we observe its performance for the past one month. Year-to-date it is -20.17% down and over the past year, the stock is showing a downside performance of -1.45%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of 2.2 while estimate for next year EPS is 7.06. In next quarter, company is expected to be making quarterly sales of $1.6B as analysts are expecting the sales for current fiscal year at $7.05B and seeing the company making $6.98B in sales next year. Moreover, analysts are in estimates of $1.93B for current-quarter revenue.
Currently, Clorox Co’s total number of outstanding shares is 123.25M with 0.20% of that held by the insiders while 83.49% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 24.51% and return on equity (ROE) at 1176.27%. It has a price to earnings ratio (P/E ratio) of 23.28 while having a 18.99 of forward P/E ratio. Stock’s beta reads 0.53. Stock has a price to book (P/B) ratio of 591.85 while price to sale or P/S ratio amounts to 2.28. Its return on asset (ROA) is 12.26% on average.
